| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6119208 | Journal of Autoimmunity | 2015 | 6 Pages |
Abstract
A long-term regimen of retreatment with RTX alone given at clinical relapse seems to be effective and safe in CV, with a low rate of infections and severe hypogammaglobulinemia.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Luca Quartuccio, Francesca Zuliani, Laura Corazza, Patrizia Scaini, Roberta Zani, Marco Lenzi, Antonio Tavoni, Marco Sebastiani, Simone Baldovino, Teresa Urraro, Francesco Saccardo, Costanza Sbreglia, Cesare Mazzaro, Piero Pioltelli, Paolo Fraticelli,